Investment Rating - The investment rating for the company is "Buy" (maintained) [3] Core Views - The company focuses on the mosquito repellent and baby care segments, positioning its products as "high quality and cost-effective," with significant strategic space due to its brand and product category management [3] - Despite a downward adjustment in the net profit forecast for 2025-2027 due to adverse weather conditions affecting sales, the company is expected to regain high growth with the launch of new baby care products [3] Financial Performance Summary - For Q3 2025, the company reported a revenue of 3.42 billion yuan, a year-on-year increase of 16.67%, and a net profit of 790 million yuan, a decrease of 2.89% year-on-year [8] - The company's total revenue for the first three quarters of 2025 reached 12.38 billion yuan, up 19.3% year-on-year, with a net profit of 2.66 billion yuan, reflecting a year-on-year increase of 1.98% [8] - The gross profit margin for Q1-Q3 2025 was 58.3%, slightly down by 0.06 percentage points year-on-year, while the gross margin for Q3 alone was 59.0%, up by 1.39 percentage points year-on-year [8] Product Category Performance - In Q1-Q3 2025, the revenue from mosquito repellent, baby care, and essential oil categories was 5.1 billion, 5.5 billion, and 1.3 billion yuan, respectively, with year-on-year growth rates of 20.9%, 24.6%, and a decline of 12.3% [8] - The mosquito repellent products saw significant sales growth due to factors like the dengue fever outbreak, while baby care product sales were impacted by higher autumn and winter temperatures [8]

Core Viewpoint - The article summarizes important announcements from various listed companies in the Shanghai and Shenzhen stock markets, providing insights for investors regarding significant corporate actions and financial performance. Group 1: Corporate Announcements - Wanrun Technology clarified that rumors about an online roadshow and large orders are false, stating no such investor relations activities have occurred recently [4] - DiAo Micro plans to acquire 100% of Rongpai Semiconductor through a combination of share issuance and cash payment, with stock resuming trading on October 21, 2025 [5][6] - Dongtu Technology is planning to issue shares to acquire assets from Beijing Gaoweike Electric Technology, with stock suspension starting October 21, 2025 [7] - Guangsheng Nonferrous Metals announced the absorption merger of two wholly-owned rare earth subsidiaries to enhance management efficiency and reduce operational costs [8] - Shan Shui Technology's actual controller and chairman was subjected to criminal coercive measures, but the company's operations remain normal [9] - Xingchen Technology completed the acquisition of 53.3087% of Shanghai Furui Kun Microelectronics, which will now be a subsidiary [10] - Yiyi Co. is planning to issue shares and cash to acquire assets, with stock suspension since October 14, 2025 [11] - Yintai Group's acquisition of Huatuo Pharmaceutical received antitrust approval, allowing the transaction to proceed [12] Group 2: Financial Performance - China Mobile reported a net profit of 31.1 billion yuan for Q3 2025, a year-on-year increase of 1.4%, with total revenue of 794.7 billion yuan for the first three quarters, up 0.4% [14] - Alloy Investment's Q3 net profit surged by 4985% to 2.68 million yuan, with revenue of 65.71 million yuan, a 21.61% increase [15] - iFlytek's Q3 net profit increased by 202.4% to 172 million yuan, with revenue of 6.078 billion yuan, up 10.02% [16] - Yonghe Co. reported a Q3 net profit of 198 million yuan, a 485.77% increase, with total revenue of 1.34 billion yuan, up 11.42% [17] - Dazhu CNC's Q3 net profit rose by 282% to 228 million yuan, with revenue of 1.521 billion yuan, a 95.19% increase [18] - Dingtong Technology's Q3 net profit grew by 125% to 61.175 million yuan, with year-to-date revenue of 1.156 billion yuan, up 64.45% [20] - Shenneng Power's Q3 net profit increased by 56.69% to 117 million yuan, with total revenue of 459 million yuan, up 33.38% [21] - Runben Co. reported a slight decline in Q3 net profit by 2.89%, totaling 78.52 million yuan, despite a revenue increase of 16.67% [22] - Dayang Bio's Q3 net profit grew by 56.12% to 29.53 million yuan, with revenue of 248 million yuan, up 5.72% [23] - Kaile Co. reported a significant increase in net profit by 159.14% for the first three quarters, totaling 21.63 million yuan [24] - China Shipbuilding expects a net profit increase of 104% to 126% for the first three quarters, estimating between 5.55 billion to 6.15 billion yuan [25] Group 3: Shareholding Changes - Zhejiang Mining's major shareholders plan to reduce their holdings by up to 3% of the company's shares [27] - Blue Arrow Electronics' shareholders intend to reduce their holdings by up to 3% [28] - Jifeng Technology's shareholders plan to reduce their holdings by up to 3% [29] Group 4: Major Contracts - Dash Smart announced a joint bid for a smart transportation project worth 96 million yuan, which represents 3.03% of the company's projected revenue for 2024 [30]

Financial Performance - China Mobile reported a net profit of 31.1 billion yuan for Q3 2025, a year-on-year increase of 1.4% [1] - iFlytek's Q3 net profit increased by 202.4%, reaching 172 million yuan, with revenue of 6.078 billion yuan, up 10.02% year-on-year [2] - China Shipbuilding expects a net profit of 5.55 to 6.15 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 104.3% to 126.39% [3] - Industrial Fulian plans to distribute a cash dividend of 3.3 yuan per 10 shares, totaling 6.551 billion yuan, which is 54.08% of its net profit for the first half of 2025 [4] - Alloy Investment reported a Q3 net profit of 2.68 million yuan, a staggering increase of 4985.25% [11] - Yonghe shares achieved a Q3 net profit of 198 million yuan, up 485.77% year-on-year [12] - Dazhu CNC's Q3 net profit grew by 282% to 228 million yuan [13] - Dingtong Technology's net profit for the first three quarters increased by 125% to 177 million yuan [14] - Shenneng Power's Q3 net profit rose by 56.69% to 117 million yuan [15] - Runben shares reported a slight decline in Q3 net profit by 2.89% [16] - Dayang Bio's Q3 net profit increased by 56.12% to 29.53 million yuan [18] - Kaile shares reported a 159.14% increase in net profit for the first three quarters [19] Corporate Actions - Wanrun Technology clarified that recent market rumors regarding online roadshows and large orders were false [5] - Dongtu Technology announced a stock suspension while planning to acquire assets from Beijing Gaoweike Electric Technology [6] - Guangsheng Nonferrous Metals is merging two wholly-owned rare earth subsidiaries to enhance operational efficiency [7] - Sanwater Technology's actual controller and chairman was taken under criminal coercive measures, but operations remain normal [8] - Xingchen Technology completed the acquisition of a 53.3087% stake in Shanghai Furui Kun Microelectronics [9] - Yiyi Co. announced a stock suspension while planning to issue shares and raise funds for asset acquisition [10] - Yingtai Group's subsidiary received antitrust approval for the acquisition of Huatuo Pharmaceutical for 369 million yuan [11] Major Contracts - Dash Intelligent won a 96 million yuan smart transportation project as the lead partner in a consortium [23]

为保证公司审计工作的独立性、客观性与持续性，经综合考虑及选聘会计师事务所的评价情况，公司拟 续聘广东司农会计师事务所（特殊普通合伙）为公司2025年度审计机构。2025年度财务报表审计费用为 90万元（含税），内部控制审计费用为30万元（含税）。若公司审计范围、内容发生重大变化，股东会 将授权董事会根据实际审计范围和内容调整审计费用。此议案已经公司第二届董事会审计委员会第六次 会议审议通过，但仍需提交公司股东会审议。 拟召开2025年第三次临时股东会 公司还计划召开2025年第三次临时股东会，将本次董事会需提交股东会审议的相关议案提交本次股东会 审议。具体内容可查阅公司同日披露于上海证券交易所网站（www.sse.com.cn）的《关于召开2025年第 三次临时股东会的通知》（公告编号：2025 - 043）。 此次董事会多项决策对润本股份未来发展意义重大，投资者可密切关注后续进展。 润本生物技术股份有限公司于2025年10月21日发布第二届董事会第十次会议决议公告，多项重要事项浮 出水面。 前三季度业绩增长，营收达12.38亿元 公告显示，2025年前三季度润本股份实现营业收入12.38亿元，同比增长19. ...

格隆汇10月20日丨润本股份(603193.SH)公布，公司拟使用任一时点总额度不超过人民币6.5亿元（含本 数）的闲置募集资金进行现金管理。本次现金管理授权期限自公司董事会审议通过之日起12个月内有 效，有效期内可以循环滚动使用。 ...

Group 1 - The core viewpoint of the article is that Runben Co., Ltd. (603193) reported its Q3 2025 financial results, showing a mixed performance with revenue growth but a decline in net profit [1] Group 2 - In Q3 2025, the company achieved an operating income of 342 million yuan, representing a year-on-year increase of 16.67% [1] - The net profit for Q3 2025 was 78.52 million yuan, which reflects a year-on-year decrease of 2.89% [1] - For the first three quarters of 2025, the total operating income reached 1.238 billion yuan, marking a year-on-year growth of 19.28% [1] - The net profit for the first three quarters of 2025 was 266 million yuan, showing a year-on-year increase of 1.98% [1] - The basic earnings per share for the company stood at 0.66 yuan [1]

申万宏源证券承销保荐有限责任公司 关于润本生物技术股份有限公司 使用部分暂时闲置募集资金进行现金管理的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"、"保 荐人"）作为润本生物技术股份有限公司（以下简称"润本股份"、"公司"）持续 督导工作的保荐人，根据《上市公司募集资金监管规则》《上海证券交易所股票 上市规则》《上海证券交易所上市公司自律监管指引第 11 号——持续督导》《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关规定，对润本 股份使用部分暂时闲置募集资金进行现金管理的事项进行了核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意润本生物技术股份有限公司首 次公开发行股票注册的批复》（证监许可[2023]1631 号），公司于 2023 年 9 月 27 日首次公开发行人民币普通股（A 股）60,690,000 股，发行价格为人民币 17.38 元/股，募集资金总额为人民币 1,054,792,200.00 元，扣除不含税的发行费用人民 币 83,563,748.31 元，实际募集资金净额为人民币 971,228,451.69 ...

智通财经APP讯，润本股份(603193.SH)披露2025年第三季度报告，公司前三季度实现营收12.38亿元， 同比增长19.28%;归属于上市公司股东的净利润2.66亿元，同比增长1.98%;扣非净利润2.51亿元，同比下 降1.79%;基本每股收益0.66元。 ...

证券代码：603193 证券简称：润本股份 公告编号 2025-043 润本生物技术股份有限公司 关于 2025 年第三季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第 3 号行业信息 披露：第十三号——化工》的要求，现将润本生物技术股份有限公司（以下简称 "公司"）2025 年第三季度主要经营数据披露如下： 注：产量包括自产、采购、委托加工数量。产量、销量为最小销售单位，包括支、瓶、盒、 包等。 二、2025 年第三季度公司主要产品和原材料的价格变动情况 （一）主要产品价格变动情况 2025 年第三季度，公司主要产品的价格详见下表： | 主要产品 | 2024 年第三季度 平均售价 | 2025 年第三季度 平均售价 | 同比变动比率 | | --- | --- | --- | --- | | 驱蚊产品系列 | 5.48 | 6.14 | 12.04% | | 婴童护理产品系列 | 7.89 | 8.51 | 7.86% | | 精油产品系列 | ...

证券代码：603193 证券简称：润本股份 公告编号： 2025-041 润本生物技术股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 重要内容提示： ● 润本生物技术股份有限公司拟续聘广东司农会计师事务所（特殊普通合伙） 作为公司 2025 年度的财务审计机构和内控审计机构。 润本生物技术股份有限公司（以下简称"公司"）于2025 年 10 月 20 日召开 第二届董事会第十次会议，审议通过了《关于续聘会计师事务所的议案》，同意续 聘广东司农会计师事务所（特殊普通合伙）（以下简称"司农会计师事务所"）为公司 2025 年度财务报告及内部控制审计机构，该事项尚需提交公司股东会审议通过，现 将有关情况公告如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 1. 基本信息 会计师事务所名称：广东司农会计师事务所（特殊普通合伙） 成立日期：2020 年 11 月 25 日 组织形式：合伙企业（特殊普通合伙） 注册地址：广州市南沙区南沙街兴沙路 6 号 704 房-2 首席合伙人：吉争雄 截至 ...